Fewer Complications With Robotic Surgery in Endometrial Cancer
(MedPage Today) -- Improved outcomes and greater uptake of minimally invasive surgery in those patients, Danish study shows (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 27, 2019 Category: Hematology Source Type: news

Do You Have What It Takes to Become the Next Intuitive Surgical?
Intuitive Surgical set a high bar for new entrants. But there are opportunities today that new surgical robotics companies can take advantage of that Intuitive didn't have when the company started out more than two decades ago. A panel of experts spoke at MD&M West in Anaheim, CA this week about the process of developing medical robotic tools and the valuable lessons learned from watching Intuitive rise to the top. "In the year 2000, if Intuitive Surgical walked into a room and said 'we're going to be worth $60 billion in 20 years' nobody on the planet would have believed them. Nobody," said Leo P...
Source: MDDI - February 7, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: R & D Source Type: news

Trice Medical to acquire SegWay Ortho
Trice Medical said today that it inked a deal to acquire SegWay Orthopaedics for an undisclosed amount. SegWay Ortho produces solutions for minimally invasive orthopedic procedures, including its flagship Endoscopic Carpal Tunnel Release system, a device intended to support minimally invasive carpal tunnel surgeries, Malvern, Penn.-based Trice Medical said. The company’s SegWay platform is also used in minimally invasive surgery for cubital tunnel syndrome, gastrocnemius equinus contracture and planar fasciitis, Trice Medical added. “We’re excited for SegWay to join forces with Trice. In just over fi...
Source: Mass Device - February 7, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Orthopedics Trice Medical Source Type: news

Minimally-invasive surgery for brain bleeds may not be better at restoring function than standard me
(American Heart Association) MISTIE III trial finds surgery for brain bleeding may not be better than medical treatment in restoring function but was better at reducing the risk of death. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2019 Category: International Medicine & Public Health Source Type: news

Removing more blood via minimally invasive surgery more likely to improve hemorrhagic stroke recover
(American Heart Association) The greater the volume of blood removed from the brain via minimally invasive surgery after a hemorrhagic stroke the greater the odds of better functional recovery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2019 Category: International Medicine & Public Health Source Type: news

Vicarious Surgical raises $10m more
Vicarious Surgical has raised another $10 million for the virtual reality-augmented robot-assisted surgery platform it’s developing, according to an SEC filing. The latest round of funding follows on the heels of a  nearly $17 million round announced in April 2018. Charlestown, Mass.-based Vicarious first reported a $2.4 million raise in January 2016 and another $800,000 in October of that year. Vicarious has said its device “combines virtual reality with proprietary human-like surgical robotics to enable surgeons to perform minimally invasive surgery through a single micro-incision,&rd...
Source: Mass Device - January 31, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Funding Roundup Robotics Surgical Vicarious Surgical Source Type: news

Draining blood from bleeding stroke may prevent death
(American Heart Association) A minimally invasive surgery combining the use of a clot-busting drug and a catheter to drain blood from the brain of hemorrhagic stroke patients reduced swelling and improved patients' prognoses, according to preliminary research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2019 Category: International Medicine & Public Health Source Type: news

JustRight Surgical rebrands to Bolder Surgical, raises $27m
Bolder Surgical, formerly known as JustRight Surgical, said today that it raised $27 million in a new round of financing to support its laparoscopic surgical devices. The round was led by River City Capital Funds and joined by Westwood Management, Providence Ventures and previous investors, the Louisville, Colo.-based company said. Funds raised in the round will support the company’s product innovation pipeline, increases in workforce and scaling commercialization. In connection with the round, Westwood Management managing partner Lair Kennedy and River Cities Capital managing partner Carter McNabb will join the comp...
Source: Mass Device - January 16, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Surgical JustRight Surgical Source Type: news

Minimally Invasive Surgery Works Well for Detached Retina
FRIDAY, Dec. 7, 2018 -- A minimally invasive treatment for retinal detachment leads to favorable outcomes, according to a study published online Nov. 20 in Ophthalmology. Roxane J. Hillier, M.B.Ch.B., from St. Michael's Hospital and the University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 7, 2018 Category: Pharmaceuticals Source Type: news

Ultrarestrictive opioid prescribing strategy associated with fewer pills dispensed
(JAMA Network) An ultrarestrictive opioid prescribing strategy was associated with a reduction in the number of pills dispensed in a study of patients having surgery   for gynecologic cancer, without changes in postoperative pain scores, complications or increases in prescription refill requests. Under the protocol,   patients having ambulatory or minimally invasive surgery weren't prescribed opioids at discharge unless they required more than five doses of oral or intravenous opioids while in the hospital. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 7, 2018 Category: International Medicine & Public Health Source Type: news

Imaging dev Lightpoint Medical raises $6m
Medical imaging dev Lightpoint Medical said today it raised approximately $6.4 million (GBP £5 million) in a new financing round slated to support the commercialization of the company’s robotic laparoscopic probe and its LightPath imaging system. Money in the round came from Cambridge Capital Group, Venture Founders, Coutts Investment Club, Envestors, Fund Twenty8, SyndicateRoom and Oxford Technology, the Chesham, U.K.-based company said. It added that it has also raised more than $3.8 million (GBP £3 million) from Horizon 2020 SME instrument and Innovate UK. “We are very proud to have supporte...
Source: Mass Device - December 6, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging lightpointmedical Source Type: news

Minimally Invasive Surgery for Intracerebral Hemorrhage Minimally Invasive Surgery for Intracerebral Hemorrhage
This meta-analysis evaluates current evidence supporting minimally invasive surgery for spontaneous ICH, examining specific techniques including endoscopic surgery and stereotactic thrombolysis.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 3, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Amsel Medical wins FDA nod for Endo Occluder
Amsel Medical said today that it won FDA 510(k) clearance for its Amsel Endo Occluder device intended for occluding blood vessels during endoscopic procedures. The Cambridge, Mass.-based company touted that the clearance is the third the company has received from the FDA so far for its portfolio of occluder devices. The Amsel Endo Occluder is a mechanical occlusion clip delivered through a fine needle intended to be deployed to transfix a target vessel while clamping it shut. The device is composed of an endoscopic litigating clip applier and clips which the company said are intended or use on tubular structures or ve...
Source: Mass Device - November 28, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Featured Regulatory/Compliance Vascular amselmedical Source Type: news

Pulse radiofrequency therapy may ease back pain, sciatica
A new minimally invasive surgery that sends pulses of energy to nerve roots near the spine could bring relief to people with acute lower back pain. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 27, 2018 Category: Consumer Health News Source Type: news

Minimally invasive surgery less effective than open surgery for cervical cancer
Early-stage cervical cancer patients who undergo a minimally invasive hysterectomy have a worse survival outlook than open surgery, two studies found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 1, 2018 Category: Consumer Health News Source Type: news

Minimally Invasive Sx May Up Mortality in Early Cervical Cancer
THURSDAY, Nov. 1, 2018 -- For patients with early-stage cervical cancer, minimally invasive surgery is associated with increased mortality and worse survival than open surgery, according to two studies published online Oct. 31 in the New England... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 1, 2018 Category: Pharmaceuticals Source Type: news

Is Less-Invasive Cervical Cancer Surgery Riskier?
Two new studies have found that the routinely used minimally invasive surgery for early stage cervical cancer is linked to a higher rate of recurrence, plus worse long-term survival, compared with more "open" surgeries. (Source: WebMD Health)
Source: WebMD Health - November 1, 2018 Category: Consumer Health News Source Type: news

For Cervical Cancer Patients, Less Invasive Surgery Is Worse For Survival
Two new studies suggest that minimally invasive surgery for early stage cervical cancer patients leads to death and recurring disease more often than standard surgery through a large incision.(Image credit: Steve Gschmeissner/Getty Images/Science Photo Library) (Source: NPR Health and Science)
Source: NPR Health and Science - October 31, 2018 Category: Consumer Health News Authors: Richard Harris Source Type: news

Less-radical surgery may pose higher death risk in early cervical cancer
(Reuters Health) - Women with early cervical cancer who opt for minimally-invasive surgery die sooner and are more likely to have their tumors reappear than those who have a conventional hysterectomy, according to two studies that could dramatically change treatment for the deadly malignancy. (Source: Reuters: Health)
Source: Reuters: Health - October 31, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Minimally invasive surgery for cervical cancer is MORE dangerous than open operations, study finds
Less invasive surgery to remove the cervix and uterus of early stage cervical cancer patients raises the risk of death later by 65%, a Massachusetts General Hospital study found. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2018 Category: Consumer Health News Source Type: news

Minimally invasive surgery not equal to open surgery for cervical cancer patients, study says
Among patients with early-stage cervical cancer, women who undergo minimally invasive operations have a greater risk of dying compared to those who undergo open surgeries, two new studies published Wednesday in the New England Journal of Medicine found. (Source: CNN.com - Health)
Source: CNN.com - Health - October 31, 2018 Category: Consumer Health News Source Type: news

Minimally Invasive Surgery Is Standard for Cervical Cancer. But A New Study Shows It ’s Not Effective
In a demonstration that newer isn’t always better, two studies published in the New England Journal of Medicine show that minimally invasive surgery techniques, including robotic surgery, lead to higher death rates from any cause than traditional, open surgery done through an incision in the abdomen. Minimally invasive surgery — or keyhole surgery, in which doctors perform operations through small incisions rather than by opening up patients and exposing them to complications — and robotic surgery have shortened recovery times and cut back on infections and bleeding. So in many cases, surgeons prefer usin...
Source: TIME: Health - October 31, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Studies Warn Against Minimally Invasive Surgery for Cervical Cancer
Compared to open surgery for cervical cancer, the less invasive approach was more likely to result in cancer recurrence and death, new studies found. (Source: NYT Health)
Source: NYT Health - October 31, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Cervical Cancer Uterine Cancer Surgery and Surgeons Human Papillomavirus (HPV) Cervix Uterus Tumors Fibroids Hysterectomies Food and Drug Administration New England Journal of Medicine Pedro T. Ramirez Johns Hopkins University Me Source Type: news

Minimally invasive surgery leads to worse survival for cervical cancer patients
(Northwestern University) Minimally invasive hysterectomy, a popular procedure for early-stage cervical cancer, turns out to result in worse overall survival for cancer patients than traditional open surgery, reports a new study. More than half of hysterectomies performed for this purpose are minimally invasive. Patients are about 1.65 times more likely to die over four years with the minimally invasive surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 31, 2018 Category: Cancer & Oncology Source Type: news

Minimally invasive surgery associated with worse survival for women with cervical cancer compared to open hysterectomy
(University of Texas M. D. Anderson Cancer Center) When comparing standard-of-care surgical options for women with early-stage cervical cancer, two studies led by researchers at The University of Texas MD Anderson Cancer Center discovered that minimally invasive radical hysterectomy is associated with higher recurrence rates and worse overall survival (OS), compared to abdominal radical hysterectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 31, 2018 Category: Cancer & Oncology Source Type: news

For early cervical cancer, open hysterectomy is safer than minimally invasive surgery
(Columbia University Irving Medical Center) A new study found that the risk of death was significantly higher for women with early cervical cancer if they had a minimally invasive hysterectomy instead of open surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 31, 2018 Category: Cancer & Oncology Source Type: news

Minimally invasive surgery for early-stage cervical cancer may increase risk of death
(Massachusetts General Hospital) A study by a multi-institutional research team, including Massachusetts General Hospital physicians, has found evidence that patients receiving minimally invasive radical hysterectomy for early-stage cervical cancer have an increased risk of death compared to patients treated with open surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 31, 2018 Category: Cancer & Oncology Source Type: news

Intuitive Surgical jumps on Q3 beats, increased procedures outlook
Shares of Intuitive Surgical (NSDQ:ISRG) got a pre-market bump today after the robot-assisted surgery pioneer posted third-quarter results that beat the consensus forecast, despite lower profits, and upped its outlook on procedure growth for the year. Sunnyvale, Calif.-based Intuitive posted profits of $292.5 million, or $2.45 per share, on sales of $920.9 million for the three months ended Sept. 30. That amounts to a -2.0% profit decline on top-line growth of 14.0% compared with Q3 2017. Adjusted to exclude one-time items, earnings per share were $2.83, 17¢ ahead of the consensus on Wall Street, where analysts w...
Source: Mass Device - October 19, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured MassDevice Earnings Roundup Robotics Wall Street Beat Intuitive Surgical Source Type: news

Significant Dialysis Development
(Houston Methodist) Eric Peden, M.D., chief of vascular surgery at Houston Methodist DeBakey Heart& Vascular Center, was the first surgeon in the US to perform minimally-invasive surgery to create access for dialysis patients with severe kidney disease. The WavelinQ ™ endoAVF System by Becton Dickson allows vascular surgeons to create a connection between an artery and vein using a technique involving magnets. The system was recently approved by the Food and Drug Administration. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 27, 2018 Category: International Medicine & Public Health Source Type: news

Wright Medical shares rise on Q2 earnings Beat
Shares in Wright Medical (NSDQ:WMGI) rose today in pre-market trading after the medical device maker beat expectations on Wall Street with its second quarter results. The Amsterdam-based company posted losses of $67.7 million, or 64¢ per share, on sales of $205.4 million for the three months ended July 1, seeing losses grow 64.5% while sales grew 14.3% compared with the same period last year. Adjusted to exclude one-time items, losses per share were 3¢, just ahead of the 6¢ loss-per-share consensus on The Street, where analysts were looking for sales of $196.8 million, which the company also topped. &ld...
Source: Mass Device - August 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat wrightmedical Source Type: news

Potrero Smartens up Its Catheter to Predict Diseases
Potrero Medical is hoping to use and machine learning to help predict diseases. To help with this goal, the San Francisco, CA-based company has raised $26.6 million in a series C round. The financing was led by China-focused healthcare investment firm GT Healthcare Capital Partners and Silicon Valley-based Sonder Capital. The company has a product on the U.S. market, the Accuryn Monitoring System, which turns a traditional urinary catheter into a smart sensor that helps to accurately monitor a patients’ vital signs in real-time. The financing proceeds will be used to further commercialize Accuryn and will also be use...
Source: MDDI - July 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Urinary monitor dev Potrero Medical closes $27m Series C
Predictive health company Potrero Medical said yesterday it closed a $26.6 million Series C funding to help support commercialization of its flagship Accuryn monitoring system. The San Francisco-based company’s Accuryn system is designed to use urinary catheters as diagnostic tools. The device provides real-time measurements of intra-abdominal pressure, urine output and core body temperature and can be integrated into hospital EMR systems, the company said. Financing in the round was led by GT Healthcare Capital Partners and Sonder Capital, Potrero Medical said. “We are excited to be a part of Potrero Medi...
Source: Mass Device - July 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics Urology Potrero Medical Source Type: news

FlexDex, Inc. Appoints New Vice President, Research and Development and Vice President, International Sales and Marketing
BRIGHTON, Mich., June 06, 2018 -- (Healthcare Sales & Marketing Network) -- FlexDex, Inc. (“FlexDex” or “Company”), a medical device company that is developing a platform of articulating laparoscopic instruments for minimally invasive surgery, announced to... Devices, Surgery, Personnel FlexDex, laparoscope, laparoscopic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 6, 2018 Category: Pharmaceuticals Source Type: news

Less Morbidity, Lower Costs Tied to MIS in Cervical Cancer
(MedPage Today) -- But minimally invasive surgery also linked to decreased survival (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 5, 2018 Category: Hematology Source Type: news

Intuitive Surgical wins expanded clearance for da Vinci SP
Intuitive Surgical (NSDQ:ISRG) said today that it won 510(k) clearance from the FDA for a new indication for its da Vinci SP robot-assisted surgery device and revealed plans to pursue other indications for the single-port device. Initially cleared in April 2014 for urological procedures, the da Vinci SP’s newest indication is for procedures requiring very narrow access from a single small incision. Sunnyvale, Calif.-based Intuitive said it plans to ask the FDA to clear transoral, transanal, and extraperitoneal applications for the SP device. “The da Vinci SP is the latest in our integra...
Source: Mass Device - June 1, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Regulatory/Compliance Robotics Surgical Urology Wall Street Beat Intuitive Surgical Source Type: news

DePuy Synthes launches Global Unite reverse fracture shoulder implant
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today announced the launch of the Global Unite reverse fracture shoulder implant designed for shoulder reconstruction procedures following complex fractures in patients with grossly deficient rotator cuffs. The newly launched system is intended to provide increased flexibility for securely reattaching the bone to the implant, which DePuy Synthes said is important for healing and function, and to allow for biological fixation to the implant stem. “I find that especially in my older patients whose bone quality doesn’t allow me to use the pla...
Source: Mass Device - May 22, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Orthopedics depuysynthes johnsonandjohnson Source Type: news

Intuitive Surgical touts inguinal hernia study
Intuitive Surgical (NSDQ:ISRG) touted a 1,254-patient study today showing that patients who underwent robotic-assisted surgery using the da Vinci system to repair an inguinal hernia had fewer complications after 30 days compared to patients who had open surgery. The study, published in Hernia: The World Journal of Hernia and Abdominal Wall Surgery, was characterized by Intuitive as the largest multi-center comparative study of robotic-assisted and open surgery for inguinal hernia repair. None of the patients in the robotic-assisted surgery group returned for reoperations related to the inguinal hernia repair proc...
Source: Mass Device - May 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Robotics Surgical Wall Street Beat Intuitive Surgical Source Type: news

Intuitive Dominates in its 1Q18 Earnings
The competition might be mounting in the surgical robotics space, but it isn’t having much of an impact on Intuitive Surgical - yet. The Sunnyvale, CA-based company managed to beat out Wall Street analysts' expectations in its latest quarterly earnings. Intuitive brought in about $848 million in the first quarter of 2018. This was a 25% increase over the $680 million the company earned this time last year. “We had a strong first quarter in pursuit of our mission with customer use of our systems at the top of our growth range, continuing momentum in new system placements, and stepwise progress in the development...
Source: MDDI - April 19, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Intuitive Surgical shares up on Street-beating Q1
Shares in Intuitive Surgical (NSDQ:ISRG) have risen in after-hours trading today after the robotic surgery giant posted first quarter 2018 earnings that beat expectations on Wall Street. The Sunnyvale, Calif.-based company posted profits of $287.3 million, or $2.44 per share, on sales of $847.5 million for the three months ended March 31, seeing the bottom line grow 58.9% while sales grew 24.7% compared with the same period last year. After adjusting for one-time items, earnings per share were still at $2.44, well ahead of the the $2.09 consensus on The Street, where analysts were looking for sales of $783.3 mill...
Source: Mass Device - April 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Robotics Wall Street Beat Intuitive Surgical Source Type: news

Vicarious Surgical comes out of stealth with $17m Series A for VR-based robot-assisted surgery device
Vicarious Surgical came out of stealth mode today by announcing a nearly $17 million Series A round for the virtual reality-augmented robot-assisted surgery platform it’s developing. Cambridge, Mass.-based Vicarious, which first reported a $2.4 million raise in January 2016 and another $800,000 in October of that year, opened the Series A round in January with a nearly $13 million installment. Today the company said Khosla Ventures and Innovation Endeavors led the $16.8 million Series A, joined by Gates Ventures, AME Cloud Ventures and Salesforce founder & CEO Marc Benioff. The proceeds are earmarked for con...
Source: Mass Device - April 17, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Robotics Wall Street Beat Vicarious Surgical Source Type: news

Unexpected Outcome in Hysterectomy Study
(MedPage Today) -- More cancer recurrences, worse survival with minimally invasive surgery (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 27, 2018 Category: Hematology Source Type: news

MIS device startup Human Xtensions wins FDA nod for HandX device
Minimally invasive surgery device start up Human Xtensions said today it won FDA 510(k) clearance for its HandX device. The HandX device is a light-weight, handheld device designed to translate a surgeon’s natural hand motions into more complex movements inside the patient, the Israel-based company said. The device is part of a series of electromechanically-simplified surgical systems the company is developing in a modular format, Human Xtension said. The company also produces smart 5mm surgical tools designed to pass through trocars to improve access and freedom of movement in MIS procedures. “We believe in te...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Surgical humanxtensions Source Type: news

Does robotic telesurgery have a future?
Although many have experimented with remote “telesurgery,” are the conditions right for commercial companies to start making an investment in a remote robotic surgical future? Although the idea of telesurgery — performing specialized procedures with robot-assisted surgical tools from a remote location — dates back to the very first research into medical robotics, the technology has yet to make a significant commercial impact. Robotic surgery is one of the hottest fields in medtech, as a raft of new entrants expand the possibilities for minimally invasive surgery. But thus far, commercialized systems...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Robotics Surgical Corindus Vascular Robotics Source Type: news

UR Medicine Leads U.S. in Minimally Invasive Surgery for Newest LVAD Heart Pump
UR Medicine cardiac surgeons recently introduced a minimally invasive approach to implanting the newest heart pump available for people with congestive heart failure. This is believed to be the first in the nation, and potentially a game-changer for patients. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - March 13, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Medtech ’ s existential crisis and how it can survive
The new EY report even includes an equation to show how medtech and other life science companies will need to deliver value: “Future value (FV) is driven by innovation (I) that focuses on outcomes with a high degree of personalization and is fueledby unlocking the power of data (D.” [Image courtesy of EY]Executives in medtech and other life sciences companies view digital health startups and high tech giants as an existential threat. To compete, they’re going to have to invest in or acquire customer engagement and personalization skills usually associated with online retailers and social networking sites,...
Source: Mass Device - March 13, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Diabetes Health Information Technology Healthcare Reform News Well Alphabet Amazon Apple EY google Source Type: news

Toddler Thrives after Endoscopic Craniosynostosis Surgery
Treatment TermsPediatric Plastic and Reconstructive SurgeryPediatric Neurology Sub-Title Minimally Invasive Surgery for Abnormal Head Shape Author Erin Hull Overview When an observant pediatrician told April Longmire and Mike Stone of Louisburg, NC that there were some irregularities in their infant ’s skull, they were instantly worried. Today, their toddler is happy and healthy following minimally invasive craniosynostosis surgery performed by Duke pediatric neurosurgeon Carrie Muh, MD. Preview Image Content Blocks ContentYou never want to have anyone say anything is wrong with your child, ” April exp...
Source: dukehealth.org: Duke Health News - March 8, 2018 Category: Consumer Health News Authors: efh7 at duke.edu Source Type: news

Determinant factors for chronic kidney disease after partial nephrectomy
(Rapamycin Press) Minimally invasive surgery appears to offer broader therapeutic scope for the renal masses without compromising oncological outcomes in proper hands. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 6, 2018 Category: International Medicine & Public Health Source Type: news

AtriCure beats the Street during Q4, analysts predict ‘ growth acceleration ’
AtriCure (Nasdaq: ATRC) — an innovator in treatments for atrial fibrillation and left atrial appendage management — is enjoying a rise in its stock value today after releasing results that beat the Street. Mason, Ohio–based AtriCure’s stock was up 67 cents per share, or 3.7%, closing at $18.99. The company reported yesterday evening that it revenue for the quarter ended Dec. 31 was up nearly 12% year-over-year, to $46.1 million. Analyst polled by Yahoo! Finance had predicted $45.4 million in revenue. Analysts Danielle Antalffy and Rebecca Wang at Leerink suspect Atricure&rsq...
Source: Mass Device - February 27, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News Cardiovascular Surgical Wall Street Beat AtriCure Inc. Source Type: news

Less-invasive heart valve replacement tied to better quality of life
(Reuters Health) - People who get minimally-invasive surgery to replace damaged heart valves have an easier time completing daily tasks and a better quality of life after the procedure, a research review suggests. (Source: Reuters: Health)
Source: Reuters: Health - February 23, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Imagin Medical enrolls 1st patients in i/Blue Imaging study
Imaging solution developer Imagin Medical said yesterday it recruited the initial subjects in a first-in-human study of its i/Blue Imaging System. The company is developing the ultrasensitive i/Blue Imaging System which it hopes will “establish a new standard of care” for detecting certain cancers and visualizing the surgical field during minimally invasive surgery, with an initial focus on bladder cancer. Initial procedures are currently being coordinated with the lead investigator, the Vancouver, Canada-based company said. “We are excited to see the study underway and are fortunate to be worki...
Source: Mass Device - January 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Imaging imaginmedical Source Type: news